73P-28192-47670 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2023-03-03
Dose 1 — Moderna
Co-administered: Flu
2023-03-04
Registered in v-safe
2023-03-04
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Fair · Fever · Sleepiness, Vomiting, Diarrhea · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Under 3 check-in
2023-03-04
Report sent to call center — days 1–6 daily, dose 1, under 3
Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · 1 call case(s)
2023-03-05
Health check-in — days 1–6 daily, dose 1, under 3
Feeling: Fair · Fever · Irritability/crying · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit

Under 3 check-in
2023-03-05
Report sent to call center — days 1–6 daily, dose 1, under 3
Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

Emergency room or emergency department visit · 1 call case(s)
2023-03-06
Call 1 — Requested Callback
2023-03-06
Call 1 — Requested Callback
2023-03-07
Call 2 — Could Not Reach Participant
2023-03-07
Callback requested for
11:00AM ET
2023-03-07
Call 2 — Could Not Reach Participant
2023-03-07
Callback requested for
11:00AM ET
2023-03-10
Health check-in — day 7, dose 1, under 3
Feeling: Fair · Fever · Sleepiness, Irritability/crying

Under 3 check-in
2023-03-17
Survey response — day 14, dose 1, under 3
MedDRA: Pyrexia — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

MedDRA releases: 2024-11
2023-03-17
Report sent to call center — day 14, dose 1, under 3
Get care from a doctor or other healthcare professional

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2023-03-20
Call 3 — Could Not Reach Participant
2023-03-20
Call 3 — Could Not Reach Participant
2023-03-20
Call 1 — Could Not Reach Participant
2023-03-23
Call X — Could Not Reach Participant
2023-03-23
Call X — Could Not Reach Participant
2023-03-23
Call 2 — Could Not Reach Participant
2023-03-24
Survey response — day 21, dose 1, under 3
MedDRA: Cough, Respiratory tract congestion, Rhinorrhoea — Feeling: Fair

MedDRA releases: 2024-11
2023-04-10
Dose 2 — Moderna
Co-administered: Flu
2023-04-12
Health check-in — days 1–6 daily, dose 2, under 3
Feeling: Good · Irritability/crying

Under 3 check-in
2023-04-13
Health check-in — days 1–6 daily, dose 2, under 3
Feeling: Good · None

Under 3 check-in
2023-04-26
Health check-in — day 14, dose 2, under 3
Feeling: Good

Under 3 check-in
2023-05-10
Health check-in — day 28, dose 2, under 3
Feeling: Good

Under 3 check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2023-03-03	Moderna	Flu
2	2023-04-10	Moderna	Flu

Call center

Reported	Outcome	VAERS-related outcome
2023-03-04	Unsuccessful
2023-03-05	Unsuccessful
2023-03-17	Unsuccessful

Free text

None.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Cough	·	·	✓
SD	Pyrexia	·	·	✓
SD	Respiratory tract congestion	·	·	✓
SD	Rhinorrhoea	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release